As of 2024-12-12, the Fair Value of Talis Biomedical Corp (TLIS) is -19.27 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.38 USD, the upside of Talis Biomedical Corp is -539.98%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -27.47 | -91.13 | -192.04 | -113.01 | -62.01 | -97.13 |
| YoY growth | -28.76% | -231.70% | -110.73% | 41.15% | 45.13% | -56.98% |
| Market Cap (mil) | 57.99 |
| P/E | |
| Forward P/E |
| EPS | -3.85 |
| Avg earnings growth rate | -56.98% |
| TTM earnings | -51.03 |